FMI weighs in on CBD-infused products at FDA hearing
WASHINGTON – Food Marketing Institute (FMI) on Friday participated in the Food and Drug Administration’s (FDA) public hearing regarding products containing cannabis or cannabis-derived compounds, including hemp and cannabidiol (CBD), as the agency considers whether and how to create a legal pathway